Cell Painting predicts impact of lung cancer variants

released
Title
Cell Painting predicts impact of lung cancer variants
Authors
Juan C. Caicedo, John Arevalo, Federica Piccioni, Mark-Anthony Bray, Cathy L. Hartland, Xiaoyun Wu, Angela N. Brooks, Alice H. Berger, Jesse S. Boehm, Anne E. Carpenter, and Shantanu Singh
Citation
Juan C. Caicedo, John Arevalo, Federica Piccioni, Mark-Anthony Bray, Cathy L. Hartland, Xiaoyun Wu, Angela N. Brooks, Alice H. Berger, Jesse S. Boehm, Anne E. Carpenter, and Shantanu Singh (2022, December 5). Cell Painting predicts impact of lung cancer variants.  
Abstract
Most variants in most genes across most organisms have an unknown impact on the function of the corresponding gene. This gap in knowledge is especially acute in cancer, where clinical sequencing of tumors now routinely reveals patient-specific variants whose functional impact on the corresponding genes is unknown, impeding clinical utility. Transcriptional profiling was able to systematically distinguish these variants of unknown significance as impactful vs. neutral in an approach called expression-based variant-impact phenotyping. We profiled a set of lung adenocarcinoma-associated somatic variants using Cell Painting, a morphological profiling assay that captures features of cells based on microscopy using six stains of cell and organelle components. Using deep-learning-extracted features from each cell’s image, we found that cell morphological profiling (cmVIP) can predict variants’ functional impact and, particularly at the single-cell level, reveals biological insights into variants that can be explored at our public online portal. Given its low cost, convenient implementation, and single-cell resolution, cmVIP profiling therefore seems promising as an avenue for using non–gene specific assays to systematically assess the impact of variants, including disease-associated alleles, on gene function.
Publication Identifiers

Attribution